Kennedy would keep legal fees from Merck cases if confirmed
Robert F. Kennedy Jr. would retain legal fees earned from litigation against drugmaker Merck if he is confirmed as President ...
Kennedy Would Keep Stake in HPV Vaccine Suit if Confirmed
Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, ...
Exclusive-Kennedy played key role in vaccine case against Merck
Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil ...
RFK Jr. says he’ll keep making money on anti-vaccine lawsuits while in office
The secretary of Health and Human Services nominee wrote in an ethics agreement that he would keep receiving contingency fees ...
RFK Jr. intends to keep financial interest in some lawsuits brought by firm that challenges pharmaceutical companies
Robert F. Kennedy, Jr. – the vaccine skeptic President Donald Trump has nominated to serve as Health and Human Services ...
devdiscourse1d
Kennedy's Controversial Nomination: A Legal Fees Debate in the Health Sector
Robert F. Kennedy Jr.'s nomination as Secretary of Health and Human Services has sparked debate due to his previously earned ...
Anti-RFK Jr. ads target GOP senators
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Anti-RFK Jr. ads target GOP senatorsA ...
health.wusf.usf.edu1d
RFK Jr. plans to keep a financial stake in lawsuits against the drugmaker Merck
RFK Jr. plans to keep collecting referral fees in lawsuits against the drug company Merck even if confirmed as HHS secretary, ...
Kennedy Jr. to keep vaccine suit stake if confirmed as health chief, FT says
Robert Kennedy Jr. will keep his share of any windfall from litigation against Merck (MRK) even if he becomes Donald Trump’s top U.S. health ...
devdiscourse18h
Health Sector: Market Shifts, Legal Battles, and Strategic Moves
A recent health news roundup explores legal, financial, and strategic developments. Highlights include Robert F. Kennedy ...
Merck and Eisai's cancer drugs fail to improve overall survival in late-stage trial
Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...
U.S. News & World Report6d
Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck
Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck By Dan Levine and Mike Spector (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against ...